GABELLI FUNDS LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 254 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 10.51 and the average weighting 0.3%.

Quarter-by-quarter ownership
GABELLI FUNDS LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2020$2,735,000
-11.7%
27,500
-15.4%
0.02%
-20.8%
Q3 2020$3,098,000
+28.8%
32,500
+51.2%
0.02%
+20.0%
Q2 2020$2,405,000
-30.8%
21,500
-55.0%
0.02%
-35.5%
Q1 2020$3,476,000
-42.3%
47,802
-17.3%
0.03%
-20.5%
Q4 2019$6,028,000
+4.8%
57,8020.0%0.04%
+2.6%
Q3 2019$5,754,000
-12.0%
57,802
+0.9%
0.04%
-9.5%
Q2 2019$6,541,000
-9.2%
57,3020.0%0.04%
-6.7%
Q1 2019$7,203,000
+31.1%
57,302
+41.5%
0.04%
+18.4%
Q4 2018$5,496,000
+17.8%
40,500
+138.2%
0.04%
+40.7%
Q3 2018$4,666,000
+32.5%
17,0000.0%0.03%
+28.6%
Q2 2018$3,522,000
-22.7%
17,000
-38.3%
0.02%
-22.2%
Q1 2018$4,554,000
+3.7%
27,575
-14.0%
0.03%
+8.0%
Q4 2017$4,392,000
-3.9%
32,075
-4.5%
0.02%
-3.8%
Q3 2017$4,571,000
-2.4%
33,575
-13.0%
0.03%
-7.1%
Q2 2017$4,683,000
+1.5%
38,575
-11.5%
0.03%
+3.7%
Q1 2017$4,612,000
+116.1%
43,575
+107.5%
0.03%
+107.7%
Q4 2016$2,134,00021,0000.01%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Knott David M Jr 115,000$7,6822.90%
VILLERE ST DENIS J & CO LLC 483,347$32,2872.52%
Monarch Partners Asset Management LLC 62,327$4,163,4441.23%
Chicago Capital, LLC 319,054$21,312,8201.18%
RICE HALL JAMES & ASSOCIATES, LLC 285,634$19,080,3511.09%
Stephens Investment Management Group LLC 454,416$30,713,9770.56%
Smith, Graham & Co., Investment Advisors, LP 65,372$4,366,8500.53%
WOODSTOCK CORP 55,014$3,674,9350.49%
Court Place Advisors, LLC 15,533$1,037,6050.38%
ISTHMUS PARTNERS, LLC 19,830$1,324,6440.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders